Literature DB >> 335823

The coronary drug project--findings with regard to estrogen, dextrothyroxine, clofibrate and niacin.

J Stamler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 335823     DOI： 10.1007/978-1-4613-4220-5_6

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  7 in total

1.  Thyroid mimetic as an option for lowering low-density lipoprotein.

Authors:  Scott M Grundy
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-10       Impact factor: 11.205

2.  The Origins and Early Evolution of Epidemiologic Research in Cardiovascular Diseases: A Tabular Record of Cohort and Case-Control Studies and Preventive Trials Initiated From 1946 to 1976.

Authors:  Henry Blackburn
Journal:  Am J Epidemiol       Date:  2019-01-01       Impact factor: 4.897

Review 3.  Nonstatin Low-Density Lipoprotein-Lowering Therapy and Cardiovascular Risk Reduction-Statement From ATVB Council.

Authors:  Robert A Hegele; Samuel S Gidding; Henry N Ginsberg; Ruth McPherson; Frederick J Raal; Daniel J Rader; Jennifer G Robinson; Francine K Welty
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-09-16       Impact factor: 8.311

4.  Estrogen in patients with prostatic cancer. An assessment of the risks and benefits.

Authors:  P Henriksson
Journal:  Drug Saf       Date:  1991 Jan-Feb       Impact factor: 5.606

Review 5.  Thyroid hormones and cardiovascular disease.

Authors:  Avais Jabbar; Alessandro Pingitore; Simon H S Pearce; Azfar Zaman; Giorgio Iervasi; Salman Razvi
Journal:  Nat Rev Cardiol       Date:  2016-11-04       Impact factor: 32.419

6.  Modified Low-Dose Triiodo-L-thyronine Therapy Safely Improves Function Following Myocardial Ischemia-Reperfusion Injury.

Authors:  Viswanathan Rajagopalan; Youhua Zhang; Christine Pol; Clifford Costello; Samantha Seitter; Ann Lehto; Olga V Savinova; Yue-Feng Chen; A Martin Gerdes
Journal:  Front Physiol       Date:  2017-04-12       Impact factor: 4.566

7.  Effects of Supra-Physiological Levothyroxine Dosages on Liver Parameters, Lipids and Lipoproteins in Healthy Volunteers: A Randomized Controlled Crossover Study.

Authors:  Barbara Sjouke; Laura P B Elbers; Bregje van Zaane; John J P Kastelein; G Kees Hovingh; Victor E A Gerdes
Journal:  Sci Rep       Date:  2017-10-26       Impact factor: 4.379
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.